Newsletter

006280 - GC Biopharma Corp.

006280 Summary
Biopharma
Stock Price & Overview
₩127,600 +600 (+0.47%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩127,600  ≈ US$91  ·  Market cap ₩1.5tn (≈ $1.1bn)
Why this page exists. Korean issuers file to DART, not the SEC, and almost nothing is published in English. Titles here are translated; where kstock has read the filing, the row carries the explanation and the amount in won and dollars. How we pick »

006280 DART Filings

DART

Half-Year Report

Periodic08/14/26title translated
DART

Fair-trade compliance programme status (notice)

Filing07/31/26title translated
DART

Preliminary Consolidated Results (Fair Disclosure)

Earnings07/31/26title translated
DART

New Facility Investment

Capex07/16/26title translated
DART

Material event report (disposal of shares in another company)

Filing07/10/26title translated
DART

Material event report (disposal of shares in another company)

Filing07/09/26title translated
DART

Corporate governance report

Filing06/01/26title translated
DART

Material event report (disposal of shares in another company)

Filing05/27/26title translated
DART

Quarterly Report

Periodic05/15/26title translated
DART

Preliminary Consolidated Results (Fair Disclosure)

Earnings05/08/26title translated
DART

Material matter affecting investment judgment

Filing05/06/26title translated
6 routine filings (insider holdings reports, IR schedules)DART

Insider / Major Shareholder Holdings Report

Ownership08/07/26title translated
DART

Change in the Largest Shareholder's Holdings

Ownership07/01/26title translated
DART

5% Ownership Report — Short Form

Ownership07/01/26title translated
DART

Change in the Largest Shareholder's Holdings

Ownership06/22/26title translated
DART

Insider / Major Shareholder Holdings Report

Ownership06/22/26title translated
DART

Change in the Largest Shareholder's Holdings

Ownership05/11/26title translated
17 filings on file, grouped where one event produced many. Source: DART, operated by Korea's Financial Supervisory Service.

Similar to 006280

SymbolLast Price
140410Mezzion Pharma Co., Ltd.₩65,000
+0.0%
068760Celltrion Pharm, Inc.₩40,850
+0.0%
007390Naturecell Co., Ltd.₩23,950
+0.2%
950160Kolon Tissue Gene, Inc.₩17,100
+1.1%
039200Oscotec, Inc.₩36,600
+1.9%
069620Daewoong Pharma₩116,100
+1.1%
290650L & C BIO Co., Ltd.₩47,900
-1.4%
127120JS Link₩33,600
+12.4%
475830Orum Therapeutics, Inc.₩55,900
+2.6%
195940HK inno.N Corporation₩42,050
+0.7%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.